JP2024526944A5 - - Google Patents

Info

Publication number
JP2024526944A5
JP2024526944A5 JP2024503869A JP2024503869A JP2024526944A5 JP 2024526944 A5 JP2024526944 A5 JP 2024526944A5 JP 2024503869 A JP2024503869 A JP 2024503869A JP 2024503869 A JP2024503869 A JP 2024503869A JP 2024526944 A5 JP2024526944 A5 JP 2024526944A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
interleukin
pharmaceutical product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024503869A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024526944A (ja
Filing date
Publication date
Priority claimed from GBGB2110721.4A external-priority patent/GB202110721D0/en
Priority claimed from GBGB2110862.6A external-priority patent/GB202110862D0/en
Application filed filed Critical
Priority claimed from PCT/EP2022/070974 external-priority patent/WO2023006765A1/en
Publication of JP2024526944A publication Critical patent/JP2024526944A/ja
Publication of JP2024526944A5 publication Critical patent/JP2024526944A5/ja
Pending legal-status Critical Current

Links

JP2024503869A 2021-07-26 2022-07-26 アルコール性肝疾患の処置および予防 Pending JP2024526944A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB2110721.4A GB202110721D0 (en) 2021-07-26 2021-07-26 Treatment and prevention of alcoholic liver disease
GB2110721.4 2021-07-26
GB2110862.6 2021-07-28
GBGB2110862.6A GB202110862D0 (en) 2021-07-28 2021-07-28 Treatment and prevention of alcoholic liver disease
PCT/EP2022/070974 WO2023006765A1 (en) 2021-07-26 2022-07-26 Treatment and prevention of alcoholic liver disease

Publications (2)

Publication Number Publication Date
JP2024526944A JP2024526944A (ja) 2024-07-19
JP2024526944A5 true JP2024526944A5 (enExample) 2025-07-14

Family

ID=83081349

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024503869A Pending JP2024526944A (ja) 2021-07-26 2022-07-26 アルコール性肝疾患の処置および予防

Country Status (4)

Country Link
US (1) US20250092126A1 (enExample)
EP (1) EP4376948A1 (enExample)
JP (1) JP2024526944A (enExample)
WO (1) WO2023006765A1 (enExample)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2259800T3 (es) 1990-06-11 2006-10-16 Gilead Sciences, Inc. Procedimientos de uso de ligandos de acido nucleico.
ES2093562B1 (es) 1995-05-26 1997-07-01 Univ Santiago Compostela Estabilizacion de sistemas coloidales mediante formacion de complejos ionicos lipido-polisacarido.
US6649192B2 (en) 1996-07-29 2003-11-18 Universidade De Santiago De Compostela Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
CA2237915A1 (en) 1998-05-19 1999-11-19 Stephen Shaughnessy Osteoporosis treatment
HK1047109A1 (zh) 1999-10-15 2003-02-07 University Of Massachusetts 作为指定基因干预工具的rna干预轨迹基因
US8182814B2 (en) 2007-10-26 2012-05-22 Csl Limited Methods of treating inflammatory airway conditions by inhibition of IL-11 activity
JP5330398B2 (ja) 2007-10-26 2013-10-30 シーエスエル、リミテッド サイトカインムテイン
US8518888B2 (en) 2008-10-14 2013-08-27 Csl Limited Method of treatment of gastrointestinal-type cancer with antagonistic antibodies to IL-11R
CN117843785A (zh) 2013-02-07 2024-04-09 Csl有限公司 Il-11r结合蛋白及其应用
GB201522186D0 (en) 2015-12-16 2016-01-27 Singapore Health Services Pte Ltd And Nat University Of Singapore The Treatment of fibrosis
US20180186871A1 (en) 2016-12-16 2018-07-05 Singapore Health Services Pte Ltd. Il-11 antibodies
GB201621431D0 (en) 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore The Decoy cytokine receptor
GB201621439D0 (en) 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore IL-11Ra Antibodies
GB201809700D0 (en) 2018-06-13 2018-08-01 Singapore Health Serv Pte Ltd IL-11 antibodies
GB201809699D0 (en) 2018-06-13 2018-08-01 Singapore Health Serv Pte Ltd IL-11 antibodies
EP3914621A1 (en) * 2019-01-21 2021-12-01 Singapore Health Services Pte. Ltd. Treatment of hepatotoxicity
BR112021021921A2 (pt) * 2019-05-03 2021-12-28 Nat Univ Singapore Agente, uso de um agente e método de tratamento ou prevenção de uma doença metabólica

Similar Documents

Publication Publication Date Title
JP2022521591A5 (enExample)
Tanaka et al. Interleukin (IL-6) immunotherapy
JP2022531591A5 (enExample)
Kishimoto et al. IL-6 revisited: from rheumatoid arthritis to CAR T cell therapy and COVID-19
Maes et al. Targeting interleukin-4 in asthma: lost in translation?
Villaescusa et al. A new approach to the management of COVID-19. Antagonists of IL-6: Siltuximab
JP2020510662A5 (enExample)
US20110318342A1 (en) Methods of using il-1 antagonists to treat autoinflammatory disease
JP2020128375A (ja) ベンラリツマブを使用して喘息の増悪率を低減する方法
JP2010500360A5 (enExample)
CN112153982A (zh) 用于通过施用il-4r抑制剂治疗特应性皮炎的方法
US20220257755A1 (en) Combination therapy for the treatment of autoimmune diseases
Hirota et al. Chemically modified interleukin-6 aptamer inhibits development of collagen-induced arthritis in cynomolgus monkeys
KR20060023968A (ko) 중증 급성 호흡기 증후군(ｓａｒｓ)의 치료를 위한 조성물및 방법
JP2017534617A (ja) Ｉｌ−６ｒ関連疾患の処置
US20240024308A1 (en) Tlr7/8 antagonists for the treatment of coronavirus infections
EP2999484A1 (en) Anti-ccl2 and anti-loxl2 combination therapy for treatment of scleroderma
Nishimoto Clinical studies in patients with Castleman’s disease, Crohn’s disease, and rheumatoid arthritis in Japan
CN105705518A (zh) 用于治疗类风湿性关节炎或作为镇痛药的中和gm-csf的抗体
JP2022549854A5 (enExample)
JP2024526944A5 (enExample)
Reiff Treatment of systemic juvenile idiopathic arthritis with tocilizumab-the role of anti-interleukin-6 therapy after a decade of treatment
CN111344043A (zh) 使用白细胞介素-17(il-17)拮抗剂治疗肌腱病的方法
Ramos et al. Targeting specific immunologic pathways in Crohn's disease
WO2021198511A1 (en) Methods and compositions for treatment of sars-cov-2 infection